Document is current
Any future updates will be listed below
-
Authors
Holst, Jens Juul https://orcid.org/0000-0001-6853-3805
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 17 July 2024
First Online: 19 August 2024
Competing interests
: Throughout the development of GLP-1RAs, J.J.H. has had numerous contacts with the pharmaceutical industry and has been a member of advisory boards and given paid lectures. Most contacts have been with Merck and Novo Nordisk. Currently, J.J.H. is a member of advisory boards for Novo Nordisk and gives occasional paid lectures for this and other companies. J.J.H. is a cofounder and a member of the board of Antag Therapeutics. J.J.H. does not have any economical engagements with any other company.
